www.fdanews.com/articles/75423-schering-plough-to-develop-centocor-compound
SCHERING-PLOUGH TO DEVELOP CENTOCOR COMPOUND
August 16, 2005
Schering-Plough Corp. (SGP.N: Quote, Profile, Research) said on Tuesday it will develop Centocor Inc.'s treatment for rheumatoid arthritis and other inflammatory diseases. The drugmaker said it will take a third-quarter charge of $125 million related to the agreement with Centocor, its development partner since 1988. Centocor is a Johnson & Johnson (JNJ.N: Quote, Profile, Research) subsidiary.